Viewing Study NCT06184750

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:00 PM
Ignite Modification Date: 2025-12-27 @ 10:27 AM
Study NCT ID: NCT06184750
Status: RECRUITING
Last Update Posted: 2025-09-15
First Post: 2023-12-27
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Breast Atypical Ductal Hyperplasia View
None Breast Atypical Lobular Hyperplasia View
None Breast Carcinoma View
None Breast Ductal Carcinoma In Situ View
None Breast Lobular Carcinoma In Situ View
None Estrogen Receptor-Positive Breast Carcinoma View
Keywords: